Revolutionary treatment gives dogs with heart disease a second chance

TEER is a minimally invasive procedure that avoids the physical trauma of open-chest surgery. Read more at straitstimes.com.

JenaValve Announces FDA Approval of the Trilogy™ Transcatheter Heart Valve System — the First and Only Transcatheter Device Approved for Symptomatic, Severe Aortic ...

JenaValve Technology, Inc., developer and manufacturer of the Trilogy™ Transcatheter Heart Valve (THV) System, today announced that the U.S. Food and Drug Administration (FDA) has granted premarket ...
The Manila Times

JenaValve Announces FDA Approval of the Trilogy™ Transcatheter Heart Valve System - the First and Only Transcatheter Device Approved for Symptomatic, Severe Aortic ...

Approval marks a historic milestone for Americans living with ssAR who are at high risk for surgery and previously had no dedicated transcatheter treatment option ...
MedPage Today on MSN

First TAVR system approved for severe aortic regurgitation

Limited launch expected for JenaValve's Trilogy System ...

Dr. Roach: Getting valve replacement surgery for a case of calcification

Vitamin K2 activates proteins that help drive calcium into the bones, away from blood vessels and heart valves. So, the ...